Covid-19: India to sell hydroxychloroquine to Malaysia

A chemist displays hydroxychloroquine tablets in New Delhi, India. - AP file pic

NEW DELHI: India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of Covid-19 patients as it partially lifts its bar on exports of the anti-malarial drug.

India is the world’s largest producer of hydroxychloroquine, sales of which have soared across the world including in the United States, especially after President Donald Trump touted it as a potential weapon against Covid-19, the disease caused by the novel coronavirus.

New Delhi had last month put a hold on exports of hydroxychloroquine to secure supplies for itself, before agreeing this month to supply it to some of its neighbours as well as “nations who have been particularly badly affected by the pandemic”.

“On April 14, india has given permission for Malaysia to import 89,100 tablets, ” Deputy Foreign Minister Kamarudin Jaffar told Reuters yesterday,

“We will try to get more hydroxychloroquine tablets from India, which is also subject to stock availability.”

Malaysia has been using hydroxychloroquine for mild to severe Covid-19 cases along with other drugs, according to its treatment protocol seen by Reuters.

Doctors and pharmacists from more than half a dozen large healthcare systems in New York, Louisiana, Massachusetts, Ohio, Washington and California have also told Reuters they are routinely using hydroxychloroquine on patients hospitalised with Covid-19.

At the same time, several said they have seen no evidence that the drug had any effect on the virus.

In one small French study, some Covid-19 patients showed improvements but there was no way to know if the drug was the reason.

Results published in April from another study in France and one in China found no benefit in patients treated with the drug.

Dozens more clinical studies are underway around the world.

Malaysia’s Health Ministry told Reuters it had “faced challenges” in securing the drug, which it said may be able to reduce the progression of the disease and lung inflammation. It said the drug has been used in Malaysia for the treatment of Covid-19 since January.

Malaysia had asked India for more than one million hydroxychloroquine tablets, two sources told Reuter.

“I am not sure if that much can be given, ” one of the sources said. “India is also giving hydroxychloroquine to some less developed countries. In Africa.”

Malaysia has the third highest number of infections of Covid-19 in South-East Asia with more than 5,000 cases, 83 of whom have died. — Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Bitcoin extends downtrend, falls 12.1% to US$47,176
Perodua targets to deliver 30,000 units in December
CPO futures likely to trade higher next week
Georgieva says examining all IMF research processes to ensure integrity
Oil steadies, paring gains as rising COVID cases spur demand worries
Omicron-fuelled volatility deals hedge funds worst monthly return since March 2020
US-listed Chinese shares take a hit as Didi to exit NYSE
Didi shares plunge more than 20% on plan to delist from NYSE
Wall St ends lower on Omicron worries, Fed taper angst
Micro impact of new variant?

Others Also Read